Delivering value across the full life cycle of biopharma therapeutics
By combining molecular science and artificial intelligence with years of experience and a world-leading clinico-genomic database, Caris aims to revolutionize cancer care and deliver on the promise of precision oncology in partnership with biopharma and industry innovators. Our goal is to find the best personalized treatment for every patient. Learn more about how these essential partnerships are powering the future of precision medicine.
Identifying novel therapeutic targets in oncology is a critical unmet need. Our proprietary end-to-end discovery platform coupled with deep genomic and matched clinical information will enhance our ability to identify and validate clinically relevant novel targets.
Learn more about Caris’ unparalleled data, innovation lab, and broad footprint to help you unlock otherwise inaccessible target discovery opportunities.
Caris solutions provide assurance to your development programs by supporting data-driven decisions. Unmatched breadth and depth of profiling coverage from a single platform enables a seamless transition from clinical trial data to real world applications.
See how Caris solutions can help accelerate development timeline, maximize program potential, and navigate complexities.
Enable the future of precision medicine with a platform built to last.
Learn how co-partnership provides an optimal approach of developing, validating and launching your novel CDx biomarker.
"*" indicates required fields